Cubist Systematic Strategies’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-300
| Closed | -$3K | – | 2799 |
|
|
2020
Q3 | $3K | Buy |
+300
| New | +$3K | ﹤0.01% | 2458 |
|
|
2020
Q2 | – | Sell |
-5,323
| Closed | -$65K | – | 2599 |
|
|
2020
Q1 | $65K | Buy |
5,323
+3,847
| +261% | +$47K | ﹤0.01% | 1977 |
|
|
2019
Q4 | $23K | Buy |
+1,476
| New | +$23K | ﹤0.01% | 2339 |
|
|
2019
Q3 | – | Sell |
-17,425
| Closed | -$230K | – | 2614 |
|
|
2019
Q2 | $230K | Buy |
+17,425
| New | +$230K | ﹤0.01% | 1976 |
|